Antoine Galou Email

VP Financial Planning Analysis . Merus N.V.

Current Roles

Employees:
292
Revenue:
$45.3M
About
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of bispecific antibody therapies (Biclonics®) to help fight cancer. Merus’ Head Quarters are located in The Netherlands, with offices in the US and collaborators around the world. As of 2016 we are listed on NASDAQ and over a period of 10 years we have several candidate drugs in clinical trials. For more information, please visit www.merus.nl
Merus N.V. Address
139 Main Street – Suite 302
Cambridge, MA
United States

Past Companies

Merus N.V.Vice President of Financial Planning Analysis
Pieris PharmaceuticalsSenior Director, Business Development and Portfolio Managament
Radius Health, Inc.Senior Director of Business Planning

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.